GRAIL (GRAL) Competitors $32.18 -1.80 (-5.30%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$32.40 +0.22 (+0.68%) As of 08/14/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. OPCH, RDNT, BTSG, SHC, WGS, SGRY, CON, PRVA, ADUS, and PGNYShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), GeneDx (WGS), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Option Care Health RadNet BrightSpring Health Services Sotera Health GeneDx Surgery Partners Concentra Group Holdings Parent Privia Health Group Addus HomeCare Progyny GRAIL (NASDAQ:GRAL) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability. Which has more volatility and risk, GRAL or OPCH? GRAIL has a beta of 3.26, indicating that its share price is 226% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Which has better valuation & earnings, GRAL or OPCH? Option Care Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGRAIL$125.60M9.22-$2.03B-$13.11-2.45Option Care Health$5.00B0.92$211.82M$1.2522.73 Is GRAL or OPCH more profitable? Option Care Health has a net margin of 3.93% compared to GRAIL's net margin of -329.86%. Option Care Health's return on equity of 17.53% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets GRAIL-329.86% -16.32% -13.69% Option Care Health 3.93%17.53%7.17% Do insiders and institutionals have more ownership in GRAL or OPCH? 98.1% of Option Care Health shares are owned by institutional investors. 1.9% of GRAIL shares are owned by company insiders. Comparatively, 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts recommend GRAL or OPCH? GRAIL presently has a consensus price target of $31.50, suggesting a potential downside of 2.11%. Option Care Health has a consensus price target of $35.75, suggesting a potential upside of 25.84%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Option Care Health 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the media favor GRAL or OPCH? In the previous week, GRAIL had 7 more articles in the media than Option Care Health. MarketBeat recorded 18 mentions for GRAIL and 11 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.69 beat GRAIL's score of 0.25 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GRAIL 4 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Option Care Health 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryOption Care Health beats GRAIL on 12 of the 16 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22B$3.10B$5.61B$9.84BDividend YieldN/A2.23%4.61%4.07%P/E Ratio-2.4520.4930.2925.74Price / Sales9.22356.37463.41115.83Price / Cash1.1843.0338.2159.48Price / Book0.438.608.826.15Net Income-$2.03B-$54.65M$3.25B$265.06M7 Day Performance-1.95%5.86%3.70%2.60%1 Month Performance-16.48%8.86%5.84%2.83%1 Year Performance102.77%13.33%29.92%25.58% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL1.0838 of 5 stars$32.18-5.3%$31.50-2.1%+109.1%$1.22B$125.60M-2.451,360News CoverageEarnings ReportOPCHOption Care Health4.7078 of 5 stars$28.26flat$35.75+26.5%-7.3%$4.59B$5.00B22.618,088Positive NewsRDNTRadNet3.3208 of 5 stars$55.77+2.0%$69.60+24.8%+9.8%$4.10B$1.83B-129.6911,021News CoverageEarnings ReportAnalyst UpgradeAnalyst RevisionBTSGBrightSpring Health Services2.6841 of 5 stars$19.36-1.4%$24.90+28.6%+93.2%$3.45B$11.27B62.4535,000SHCSotera Health1.2086 of 5 stars$11.28+1.2%$16.00+41.8%+7.1%$3.16B$1.10B141.023,000Earnings ReportWGSGeneDx1.9589 of 5 stars$108.35+6.6%$101.63-6.2%+263.2%$2.90B$362.32M2,167.001,200Gap DownSGRYSurgery Partners2.9283 of 5 stars$22.22+4.4%$33.33+50.0%-22.8%$2.73B$3.11B-14.5215,000CONConcentra Group Holdings Parent2.1864 of 5 stars$19.79+1.6%$28.50+44.0%+1.6%$2.50B$1.90B14.7711,250Dividend AnnouncementPRVAPrivia Health Group3.4227 of 5 stars$19.47+3.2%$28.38+45.8%+7.4%$2.30B$1.74B162.261,140Earnings ReportAnalyst ForecastADUSAddus HomeCare4.9449 of 5 stars$106.96+1.9%$142.57+33.3%-11.1%$1.93B$1.15B24.1449,703Positive NewsPGNYProgyny2.1108 of 5 stars$23.18+3.1%$24.82+7.1%+10.0%$1.93B$1.17B40.67310 Related Companies and Tools Related Companies Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives GeneDx Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Addus HomeCare Alternatives Progyny Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.